Eosinophils in gastrointestinal inflammation: From innocent bystanders to offenders

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 10, 2002, Pages 1117-1125

  Egesten, Arne ^a   Andersson, P ^a   Persson, T ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; EOTAXIN; ICOSANOID; IMMUNOGLOBULIN FC FRAGMENT;

ALLERGIC ASTHMA; ANTIGEN PRESENTATION; CELIAC DISEASE; CELL ACTIVATION; CELL DIFFERENTIATION; CHEMOTAXIS; CHURG STRAUSS SYNDROME; COLITIS; CROHN DISEASE; DIGESTIVE SYSTEM INFLAMMATION; EOSINOPHIL; EOSINOPHILIC GASTROENTERITIS; ESOPHAGITIS; FOOD ALLERGY; GASTRITIS; GASTROINTESTINAL TUMOR; GRAFT REJECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HELMINTHIASIS; HYPEREOSINOPHILIC SYNDROME; IMMUNOBIOLOGY; IMMUNOSURVEILLANCE; PARASITE IMMUNITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

DIGESTIVE SYSTEM; EOSINOPHILS; GASTROENTERITIS; HUMANS;

EID: 0036794895     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202760373308     Document Type: Review

References (102)

1. Spry CJF. Eosinophils. A comprehensive review and guide to the scientific and medical literature. Oxford: Oxford University Press; 1988.
2. Rosenberg HF. The eosinophil. In: Gallin JI, Snyderman R, editors. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Williams & Wilkins Co.; 1999. p. 61-77.
3. Egesten A, Calafat J, Janssen H, Knol EF, Malm J, Persson T. Granules of human eosinophilic leukocytes and mechanisms involved in their mobilization. Clin Exp Allergy 2001;31:1173-88.
4. Broide D, Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev 2001;179:163-72.
5. Erle DJ, Briskin MJ, Butcher EC, Garcia-Pardo A, Lazarovits AI, Tidswell M. Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J Immunol 1994;153:517-28.
6. Mishra A, Hogan SP, Brandt EB, Wagner N, Crossman MW, Foster PS. et al. Enterocyte expression of the eotaxin and IL-5 transgenes induces compartmentalized dysregulation of eosinophil trafficking. J Biol Chem 2002;277:4406-412.
7. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. Peyer's patch eosinophils: identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin. Blood 2000;96:1538-44.
8. Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 1999;103:1719-27.
9. Mosmann TR, Coffman RL. Th 1 and Th 2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
10. Lucey DR. Evolution of the type- 1 (Th1)-type-2 (Th2) cytokine paradigm. Infect Dis Clin North Am 1999;13:1-9.
11. Walsh GM. Eosinophil apoptosis: mechanisms and clinical relevance in asthmatic and allergic inflammation. Br J Haematol 2000;111:61-7.
12. Kita H, Adolphson CR, Gleich GJ. Biology of eosinophils. In: Middleton E, Reed CE, Ellis EF, et al., editors. Allergy. Principles and practice, 5th ed. St. Louis: Mosby Year Book, Inc.; 1998. p. 242-60.
13. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:642-6.
14. Lamkhioued B, Gounni AS, Gruart V, Pierce A, Capron A, Capron M. Human eosinophils expressa receptor for secretory component. Role in secretory IgA-dependent activation. Eur J Immunol 1995;25:117-25.
15. Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol 1998;161:4340-6.
16. Rosenberg HF. Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem 1995;270:7876-81.
17. Young JD, Peterson CG, Venge P, Cohn ZA. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986;321:613-6.
18. Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis 1998;177:1458-64.
19. Klebanoff SJ.. Oxygen metabolites from phagocytes. In: Gallin JI, Snyderman R, editor. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Wiliams & Wilkins Co.; 1999. p. 721-68.
20. Wu W, Samoszuk MK, Comhair SA, Thomassen MJ, Farver CF, Dweik RA, et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 2000;105:1455-63.
21. Persson T, Andersson P, Bodelsson M, Laurell M, Malm J, Egesten A. Bactericidal activity of human eosinophilic granulocytes against Escherichia coli. Infect Immun 2001;69: 3591-6.
22. Bozza PT, Yu W, Weller PF. Mechanisms of formation and function of eosinophil lipid bodies: inducible intracellular sites involved in arachidonic acid metabolism. Mem Inst Oswaldo Cruz 1997;92:135-40.
23. Henderson WR Jr, Lewis DB, Albert RK, Zhang Y, Lamm WJ, Chiang GK, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 1996; 184:1483-94.
24. Blom M, Tool AT, Roos D, Verhoeven AJ. Priming of human eosinophils by platelet-activating factor enhances the number of cells able to bind and respond to opsonized particles. J Immunol 1992;149:3672-7.
25. Lacy P, Moqbel R. Eosinophil cytokines. Chem Immunol 2000; 76:134-55.
26. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM. CXC chemokines in angiogenesis. J Leukoc Biol 2000;68:1-8.
27. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520-4.
28. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-79.
29. WHO Expert Committee on Onchocerciasis: third report. Technical Report Series No. 752. Geneva: World Health Organization; 1987. p. 38-42.
30. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 1993;150:2554-62.
31. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000:105:945-53.
32. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356: 2144-8.
33. Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2149-53.
34. Persson CG, Erjefalt JS, Korsgren M, Sundler F. The mouse trap. Trends Pharmacol Sci 1997;18:465-7.
35. Denzler KL, Borchers MT, Crosby JR, Cieslewicz G, Hines EM, Justice J, et al. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol 2001;167:1672-82.
36. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998;252:418-25.
37. Matthews AN, Friend DS, Zimmermann N, Sarafi MN, Luster AD, Pearlman E, et al. Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA. 1998;95:6273-8.
38. Wilson ME, Weller PF. Eosinophilia. In: Guerrant RL, Walker DH, Weller PF, editors. Essentials of tropical infectious diseases. Philadelphia: Churchill Livingstone; 2001. p. 16-30.
39. Behm CA, Ovington KS. The role of eosinophils in parasitic infections: insights from genetically modified mice. Parasitol Today 2000;16:202-9.
40. Meeusen ENT, Balic A. Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 2000;16:95-101.
41. Butterfield JH, Gleich GJ. Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. J Allergy Clin Immunol 1994;94:1318-26.
42. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
43. Churg A. Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 2001:14:1284-93.
44. Weller PF, Plaut M, Taggart V, Trontell A. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 2001;108:175-83.
45. Wechsler ME, Finn D, Gunawardena D, Westlake R, Barker A, Haranath SP. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000;117:708-13.
46. Iwasaki K, Torisu M, Fujimura T. Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer. Cancer 1986;58:1321-7.
47. Shepherd NA, Blackshaw AJ, Hall PA, Bostad L, Coates PJ, Lowe DG, et al. Malignant lymphoma with eosinophilia of the gastrointestinal tract. Histopathology 1987;11:115-30.
48. Pretlow TP, Keith EF, Cryar AK, Bartolucci AA, Pitts AM, Pretlow TG 2nd, et al. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res 1983: 43:2997-3000.
49. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, Aljama A. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma, Cancer 2000;88:1544-8.
50. Wong DT, Bowen SM, Elovic A. Gallagher GT, Weller PF. Eosinophil ablation and tumor development. Oral Oncol 1999; 35:496-501.
51. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992:257:548-51.
52. Kruger-Krasagakes S, Li W, Richter G, Diamantstein T, Blankenstein T. Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth. Eur J Immunol 1993;23:992-5.
53. Macdonald FI, Ashraf S, Picton M, Dyer PA, Parrott NR, Short CD, et al. Banff criteria as predictors of outcome following acute renal allograft rejection. Nephrol Dial Transplant 1999: 14:1692-7.
54. Kormendi F, Amend WJ Jr. The importance of eosinophil cells in kidney allograft rejection. Transplantation 1988;45:537-9.
55. Nagral A, Ben-Ari Z, Dhillon AP, Burroughs AK. Eosinophils in acute cellular rejection in liver allografts. Liver Transpl Surg 1998;4:355-62.
56. Le Moine A, Flamand V, Demoor FX, Noel JC, Surquin M, Kiss R, et al. Criticai roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest 1999;103:1659-67.
57. Ahmad M, Soetikno RM, Ahmed A. The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol 2000;30:242-4.
58. Orenstein SR, Shalaby TM, Di Lorenzo C, Putnam PE, Sigurdsson L, Kocoshis SA. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000;95:1422-30.
59. Walsh SV, Antonioli DA, Goldman H, Fox VL, Bousvaros A, Leichtner AM, et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 1999;23:390-6.
60. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response. J Allergy Clin Immunol 2001;108:954-61.
61. Liacouras CA, Markowitz JE. Eosinophilic esophagitis: a subset of eosinophilic gastroenteritis. Curr Gastroenterol Rep 1999;1:253-8.
62. Furuta GT. Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr 1998;26:468-71.
63. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982;83:818-23.
64. Ruchelli E, Wenner W, Voytek T, Brown K, Liacouras C. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol 1999;2:15-8.
65. Justinich CJ, Ricci A Jr, Kalafus DA, Treem WR, Hyams JS, Kreutzer DL. Activated eosinophils in esophagitis in children: a transmission electron microscopic study. J Pediatr Gastroenterol Nutr 1997;25:194-8.
66. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001;107:83-90.
67. Wallaert B, Desreumaux P, Copin MC, Tillie I, Benard A, Colombel JF, et al. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med 1995;182:1897-904.
68. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci 1991;36:435-40.
69. Herrera-Goepfert R, Arista-Nasr J, Alba-Campomanes A. Pathologic features of the gastric mucosa adjacent to primary MALT-lymphomas. J Clin Gastroenterol 1999;29:266-9.
70. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990;31:54-8.
71. Caldwell JH. Eosinophilic gastroenteritis. Curr Treat Options Gastroenterol 2002;5:9-16.
72. Lee M, Hodges WG, Huggins TL, Lee EL. Eosinophilic gastroenteritis. South Med J 1996;89:189-94.
73. Colombel JF, Torpier G, Janin A, Klein O, Cortot A, Capron M. Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein. Gut 1992;33:1190-4.
74. Lavo B, Knutson L, Loof L, Odlind B, Venge P, Hallgren R. Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease. Am J Med 1989;87:655-60.
75. Bischoff SC, Mayer JH, Manns MP. Allergy and the gut. Int Arch Allergy Immunol 2000;121:270-83.
76. Schwab D, Raithel M, Klein P, Winterkamp S, Weidenhiller M, Radespiel-Troeger M, et al. Immunoglobulin E and eosinophilic cationic protein in segmental lavage fluid of the small and large bowel identify patients with food allergy. Am J Gastroenterol 2001;96:508-14.
77. Machida HM, Catto Smith AG, Gall DG, Trevenen C, Scott RB. Allergic colitis in infancy: clinical and pathologic aspects. J Pediatr Gastroenterol Nutr 1994;19:22-6.
78. Sampson HA, Anderson JA. Summary and recommendations: classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children. J Pediatr Gastroenterol Nutr 2000;30:87-94.
79. Lake AM. Food-induced eosinophilic proctocolitis. J Pediatr Gastroenterol Nutr 2000;30:58-60.
80. Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol. 2001;2:353-60.
81. Sleisinger MH, Fordtran JS. Gastrointestinal disease pathophysiology, diagnosis, management. Philadelphia: Saunders; 1989. p. 1402-18.
82. Chen W, Paulus B, Shu D, Wilson, Chadwick V. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand J Gastroenterol 2001;36:515-20.
83. D'Arienzo A, Manguso F, Astarita C, D'Armiento FP, Scarpa R, Gargano D, et al. Allergy and mucosal eosinophil infiltrate in ulcerative colitis. Scand J Gastroenterol 2000;35:624-31.
84. Levy AM, Gleich GJ, Sandborn WJ, Tremaine WJ, Steiner BL, Phillips SF. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc 1997;72:117-23.
85. Carlson M, Raab Y, Peterson C, Hallgren R, Venge P. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol 1999;94:1876-83.
86. Oshitani N, Campbell A, Kitano A, Kobayashi K. Jewell DP. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J Pathol 1996;178:95-9.
87. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
88. Stevceva L. Pavli P, Husband A, Matthaei KI, Young IG, Doe WF. Eosinophilia is attenuated in experimental colitis induced in IL-5 deficient mice. Genes Immun 2000;1:213-8.
89. Grip O. Malm J, Veress B, Bjartell A, Lindgren S, Egesten A. Increased presence of cells containing transforming growth factor alpha (TGF-alpha) in ulcerative colitis, both during active inflammation and in remission. Eur J Gastroenterol Hepatol 2000;12:761-6.
90. Van Deventer SJ. Immunotherapy of Crohn's disease. Scand J Immunol 2000;51:18-22.
91. Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 1995;37:242-5.
92. Beil WJ, Weller PF, Peppercorn MA, Galli SJ, Dvorak AM. Ultrastructural immunogold localization of subcellular sites of TNF-alpha in colonic Crohn's disease. J Leukoc Biol 1995;58:284-98.
93. Mansi A, Cucchiara S, Greco L, Sarnelli P, Pisanti C, Franco MT, et al. Bronchial hyperresponsiveness in children and adolescents with Crohn's disease. Am J Respir Crit Care Med 2000;161:1051-4.
94. Louis E, Louis R, Shute J, Lau L, Franchimont D, Lamproye A, et al. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy. 1999;29:660-66.
95. Bohr J. A review of collagenous colitis. Scand J Gastroenterol 1998;33:2-9.
96. Aigner T, Neureiter D, Muller S, Kuspert G, Belke J, Kirchner T. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology 1997;113:136-43.
97. Järnerot G, Tysk C, Bohr J, Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology 1995;109:449-55.
98. Levy AM, Yamazaki K, Van Keulen VP, Burgart LJ, Sandborn WJ, Phillips SF, et al. Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis. Am J Gastroenterol 2001;96:1522-8.
99. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261:4337-45.
100. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, et al. Transforming growth factor beta modulates the expression of colagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-904.
101. Ståhle-Bäckdahl M, Maim J, Veress B, Benoni C, Bruce K, Egesten A. Increased presence of eosinophilic granulocytes expressing transforming growth factor-betal in collagenous colitis. Scand J Gastroenterol 2000;35:742-6.
102. Taha Y, Carlson M, Thorn M, Loof L, Raab Y. Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis. Dig Dis Sci 2001;46:888-97.